Lab marker

Non-HDL-C

Non-HDL cholesterol

Cholesterol in all atherogenic particles, a closer cousin of ApoB than LDL-C, calculated for free from the lipid panel.

Moderate relevance2 cited sourcesNo fastingFree (computed).nutritionmovement

What it measures

Total cholesterol minus HDL cholesterol. Captures the cholesterol cargo in every atherogenic particle (LDL, VLDL, IDL, Lp(a), remnants), closer to particle burden than LDL-C alone.

Reference context

2 guideline sources

Typically 30 mg/dL higher than the matched LDL-C target in the same risk category. Useful when triglycerides are elevated and LDL-C calculation is unreliable.

Population context: consult guideline targets below

Mechanism

Why moving this marker matters

Because non-HDL-C includes triglyceride-rich remnant lipoprotein cholesterol, it captures dysmetabolic patterns that LDL-C misses. Predicts CV events at least as well as LDL-C and may be modestly superior in people with elevated triglycerides.

Guideline targets

What major guidelines recommend

ESC 2021 (high risk)

Strong

<100 mg/dL (<2.6 mmol/L)

ESC 2021 (very-high risk)

Strong

<85 mg/dL (<2.2 mmol/L)

How to measure

The test, where to get it, when to repeat

Method

Calculated automatically by modern lipid panels (Total cholesterol − HDL-C). No separate test required.

Where

Standard lipid panel everywhere.

Typical cost

Free (computed).

Fasting

Not required

When to test

  • ESC 2021

    40+

    Reported alongside LDL-C in modern panels.

Where to test

Independent labs offering this test

Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.

Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.

Context

Reading the numbers

Typically 30 mg/dL higher than the matched LDL-C target in the same risk category. Useful when triglycerides are elevated and LDL-C calculation is unreliable.

Caveats

Less affected by recent meals than calculated LDL-C; can be used non-fasting.

Practices

What's been shown to influence this marker

PREDIMED (NEJM 2018): a Mediterranean diet supplemented with extra-virgin olive oil or nuts led to fewer major cardiovascular events than a reduced-fat control diet. The trial did not report non-HDL-C, so any effect on non-HDL-C itself is not established.

Mediterranean dietary patternHabit
Moderate evidence

Mediterranean dietary pattern

Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.

Read full evidence

Why

The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.

Slot in your day

With a meal

How to do it

How

Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.

Sticking with it

Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.

Markers this may influence

Evidence

At a glance

Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.

GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)

30g fiber/dayHabit
Moderate evidence

30g fiber/day

Most adults eat about half the recommended amount. Higher intake is associated with lower mortality in observational studies.

Read full evidence

Why

Fiber feeds gut microbiota and slows glucose absorption. In observational studies, higher intake is associated with lower cardiovascular and all-cause mortality, though such data cannot show cause. WHO recommends at least 25 g/day for adults. Whole foods (legumes, vegetables, oats, berries) are better sources than supplements.

Slot in your day

With a meal

How to do it

How

Add a serving of beans/lentils most days. Berries with breakfast. Vegetables at lunch and dinner. Tracked once for a week, the gap to 30g becomes obvious.

Markers this may influence

Evidence

At a glance

Veronese 2018 Am J Clin Nutr umbrella review (18 meta-analyses, 298 prospective studies): higher fibre intake was associated with lower cardiovascular and all-cause mortality, graded convincing, though observational data cannot show cause. WHO's 2023 carbohydrate guideline recommends at least 25 g a day of naturally occurring fibre for adults, citing moderate-certainty evidence of lower cardiovascular disease, type 2 diabetes and cancer risk.

GRADE certainty: Moderate — reported by WHO 2023 carbohydrate intake guideline (moderate certainty for lower risk of cardiovascular disease, type 2 diabetes and cancer)

See also

Related markers

Take to your physician

Worth discussing

  • Whether non-HDL-C or ApoB is the more useful metric in your situation.
  • If your LDL-C and non-HDL-C diverge meaningfully, what that tells you about your lipid pattern.

Sources

Cited literature

Last reviewed October 2026

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading